facility other than home, and death. We also analyzed the effects of patient and hospital characteristics on these outcome measures.
Clinical Material and Methods

Data Source
Data for the years from 1993 to 2002 were obtained from the NIS hospital discharge database. The NIS is maintained by the AHRQ and represents the largest all-payer inpatient care database in the US. It contains data from approximately 8 million discharges annually from 1004 hospitals located in 37 states. 7 These discharges represent approximately 85% of all nonfederal hospital discharges in the US. Additional information about the NIS is available at http:// www.ahcpr.gov/data/hcup/nisintro.htm.
Inclusion Criteria
All patients from 1993 to 2002 with a diagnosis of Cushing's disease (ICD-9 code 255.0) and who had undergone TSS (ICD-9 procedure codes 07.14, 07.62, and 07.65) were included in the present study.
Patient and Hospital Characteristics
Independent variables such as patient age, sex, race, and comorbidities as well as hospital size and year of treatment were abstracted from the NIS database. Age was stratified into four intervals: younger than 18, 18 to 44, 45 to 64, and younger than 64 years. Race was categorized as white, black, and other. The year of treatment was classified into two groups: 1993 to 1997 and 1998 to 2002. The frequencies of medical comorbidities as described and listed by Elixhauser et al. 5 were calculated using the AHRQ software (http//www.hcup.-us.ahrq.gov/tools_software.jsp; last accessed 06/10/2007). A single comorbidity score was then tabulated and used in the analysis.
Using the unique hospital identifier for each hospital, the annual hospital volume was abstracted. Annual hospital volume was then divided into quintiles representing very low, low, medium, high, and very high volumes. The numeric thresholds for volume were two cases/year (very low), five cases/year (low), 14 cases/year (medium), 23 cases/year (high), and more than 23 cases/year (very high).
Outcome Variables
The primary outcomes were adverse outcome and complication rate. Adverse outcome was defined as death or discharge to an institution other than home. Complications were classified using the following ICD-9 codes: postoperative neurological complications (997.00-997.09), pulmonary complications (518.81-518. 85 ities (276.0-276.9), iatrogenic panhypopituitarism (253.7), and cerebrospinal fluid rhinorrhea (349.81). The number of discharges, deaths, LOS, and hospital charges were also abstracted from the NIS dataset. United States census data were used to adjust population estimates per 1,000,000 of the US population.
Statistical Analysis
Categorical outcomes were compared using the chisquare analysis. Probability values less than 0.05 were accepted as significant. A multivariate logistic regression model was constructed for the multivariate analysis; only those variables that satisfied the screening cutoff of p Ͻ 0.1 on univariate analysis were incorporated into the multivariate analysis. The multivariate ORs are reported with the 95% CIs. For multivariate analysis, the LOS was categorized into normal (Յ 75th percentile LOS of 6 days) and prolonged LOS (Ͼ 75th percentile LOS of 6 days). Multivariate analysis was performed for the following binary outcome variables: complications, adverse outcome, and LOS. Extrapolations to the entire US population were performed using the SAS PROC SURVEY methodology. All data were analyzed using SAS, version 9.1 (SAS Institute, Inc.) running on Windows XP Pro (Microsoft Corp.).
Results
Three thousand five hundred twenty-five patients were estimated as having undergone TSS for Cushing's disease in the US between 1993 and 2002 ( Fig. 1) . A small increase in the number of cases between 1993 and 2002 was noted. Patient and hospital characteristics are outlined in Table 1 . Patients in the age group from 18 to 44 years represented more than 60% of the study population. Fewer than 5% of the patients were pediatric (Ͻ 18 years). Almost 82% of the patients were female and 76% were Caucasian. Thirtythree percent of patients had no preoperative comorbidities, and the majority of patients (81.6%) underwent TSS for Cushing's disease at a large hospital. The total inhospital complication rate was 42.1%, and 30.6% of the patients had at least one complication ( Table 2 ). The inhospital mortality rate was 0.7%. The mean and median LOSs were 5.5 and 4.0 days, respectively. The LOS of patients after TSS for Cushing's disease declined significantly from 1993 to 2002 (Fig. 2) . Table 3 features the frequencies of 10 classes of complications: DI, fluid and electrolyte abnormalities, iatrogenic panhypopituitarism, pulmonary complications, postoperative hemorrhage/hematoma, thromboembolic signs, renal/ urinary complications, cardiac symptoms, infection, and postoperative neurological signs. Diabetes insipidus (15%) and fluid and electrolyte abnormalities (12.5%) were the most frequent symptoms. Neurological complications occurred in 5.6% of patients and postoperative hemorrhage
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Outcomes following transsphenoidal surgery 3 or hematoma in 2.6%. The effects of complications on mortality rate, LOS, adverse outcome, and hospital charges are featured in Table 4 . With just one postoperative complication, the mean LOS increased by 3 days, the rate of adverse outcome increased from 1.4 to 4.3%, and the hospital charges increased by more than US $7000.
Multivariate analysis showed that the odds of a complication were higher in patients with preoperative comorbidities. A single comorbidity increased the odds of a complication 1.6-fold (OR 1.6, 95% CI 1.01-2.5), and two comorbidities increased the odds of a complication 1.8-fold (OR 1.8, 95% CI 1.2-2.8). Multivariate analysis revealed age, complications, and sex as significant factors affecting adverse outcome (Table 5) . Having a single postoperative complication almost quadrupled the odds of an adverse outcome (OR 3.8). Moreover, women were 0.3 times less likely than men to have an adverse outcome. Multivariate analysis of LOS showed a prolonged hospital stay for older patients, patients with multiple comorbidities, and those with postoperative complications (Table 6 ). Patients in the 1998 to 2002 treatment group (OR 0.4) were less likely to have a prolonged LOS than were those in the 1993 to 1997 treatment group.
Discussion
We reported the outcomes of TSS for Cushing's disease between 1993 and 2002 from a nationally representative sample of US hospitals. The present analysis included 3525 admissions. The inhospital mortality rate was 0.7%, and the inpatient complication rate was 42%. Approximately 30% of cases had one or more postoperative complications during the inpatient hospitalization. Authors of previous single-institution series have reported complication rates from 9 to 51%. 1, 8, 11, 13 Given that the two most frequent complications, DI and fluid and electrolyte abnormalities, are often transient and may be delayed, complication rates figured from assessments performed after discharge may differ from those calculated from inpatient observations. Because of the limitations of the NIS dataset, we were unable to identify the fluid and electrolyte abnormalities caused by DI. Hence, in patients with electrolyte abnormalities caused by DI, two separate complications were coded. The use of this method may have overestimated the true complication rate in our analysis. In addition, the 15% incidence of DI in the current study represents the rate of transient DI and likely is an overestimate of permanent DI. Determining the rate of permanent DI requires an assessment of endocrine function several months after TSS. Given that the NIS contains information on inpatient admissions only and does not track patients after discharge, determining the incidence of permanent DI was not possible.
Utilizing the NIS, Barker et al. 2 analyzed outcomes after TSS for all types of pituitary tumors. They reported that 26.5% of patients had one or more complications, with DI and fluid and electrolyte abnormalities occurring in 10.5 and 8.8% of the patients, respectively. In our analysis of patients with Cushing's disease, 15% had DI and 12.5% National estimates of morbidity, death, and the effect of postoperative complications on resource utilization and outcomes for surgically treated Cushing's disease have not been reported. From a healthcare systems analysis perspective, it is important to quantify the effects of postoperative complications on patient outcomes and resource utilization. We found that just one postoperative complication increases the mean LOS by 3 days, more than triples the odds of an adverse outcome, and increases hospital charges dramatically (Table 4) . Therefore, the avoidance, early recognition, and prompt management of complications are extremely important for the efficient surgical care of patients with Cushing's disease.
Comorbidities negatively affect postoperative outcomes in neurosurgery. In our analysis, the results of multivariate logistic regressions demonstrated a significant correlation between the presence of comorbidities and the complication rate. For example, patients with two comorbidities were almost two times more likely to have a complication than those with no comorbidities. Moreover, three or more comorbidities increased the odds of a prolonged hospital stay. Independent of other factors such as comorbidities, advanced age and male sex were correlated with higher rates of adverse outcome and longer LOSs. Patients older than 64 years of age were more than twice as likely to have a prolonged LOS and more than 20 times more likely to have an adverse outcome than those who were 18 to 44 years of age.
Barker and associates 2 have reported a correlation between surgical outcome and the number of procedures performed annually at a given hospital. Lower complication rates and superior outcomes following TSS for pituitary tumors of all types were noted at high-volume centers. Our analysis of the NIS data for such a volume effect specifically for TSS for Cushing's disease revealed a trend toward lower complication rates at high-volume hospitals, but this trend was not significant, perhaps because of the relatively small sample size.
Conclusions
In summary, we provided a national perspective on inpatient complications and outcomes following TSS for Cushing's disease in the US. Postoperative complications have a strong undesirable effect on LOS, discharge disposition, and resource utilization. Furthermore, we identified advanced age and preoperative comorbidity as important risk factors for undesirable outcomes, and we quantified their effect on these outcomes.
